Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV InfectionsLymphoproliferative Disorders

Interventions

DRUG

A-007

Trial Locations (1)

DEKK - TEC Inc, New Orleans

All Listed Sponsors

lead

DEKK-TEC, Inc.

INDUSTRY